Novel and Emerging Therapeutic Strategies in the Management of Non-Small Cell Lung Cancer
Novel and Emerging Therapeutic Strategies in the Management of Non-Small Cell Lung Cancer
Featuring perspectives from Dr Matthew Gubens.
1.25 AMA PRA Category 1 Credits™
To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CME credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.
|